The effects of board heterogeneity of firm’s innovation - A case study of the Chinese pharmaceutical companies
This paper extends the literature examining the association between board directors heterogeneity and firm innovation. Based on a collection of theories, such as upper echelons theory, and previous studies, the research employs a panel dataset comprising 1185 firm-year observations of 219 corporatio...
| Main Author: | |
|---|---|
| Format: | Dissertation (University of Nottingham only) |
| Language: | English |
| Published: |
2022
|
| Online Access: | https://eprints.nottingham.ac.uk/67743/ |
| _version_ | 1848800445460381696 |
|---|---|
| author | Wang, Si-Yu |
| author_facet | Wang, Si-Yu |
| author_sort | Wang, Si-Yu |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | This paper extends the literature examining the association between board directors heterogeneity and firm innovation. Based on a collection of theories, such as upper echelons theory, and previous studies, the research employs a panel dataset comprising 1185 firm-year observations of 219 corporations in the Chinese pharmaceutical industry, covering 6 years from 2015 to 2020. R&D investment intensity is used as the measurement of a firm’s innovation level. The empirical findings suggest that functional background heterogeneity could significantly impede firms’ innovation performance and overseas background has a significantly positive relationship with R&D intensity. Besides, age, gender and educational background heterogeneity could also affect a corporation’s innovation level. The paper concludes by providing academic and practical recommendations on how to strengthen firms' innovation in the Chinese pharmaceutical industry. The research findings also provide opportunities and directions for future research. |
| first_indexed | 2025-11-14T20:51:40Z |
| format | Dissertation (University of Nottingham only) |
| id | nottingham-67743 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-14T20:51:40Z |
| publishDate | 2022 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-677432023-04-25T14:32:36Z https://eprints.nottingham.ac.uk/67743/ The effects of board heterogeneity of firm’s innovation - A case study of the Chinese pharmaceutical companies Wang, Si-Yu This paper extends the literature examining the association between board directors heterogeneity and firm innovation. Based on a collection of theories, such as upper echelons theory, and previous studies, the research employs a panel dataset comprising 1185 firm-year observations of 219 corporations in the Chinese pharmaceutical industry, covering 6 years from 2015 to 2020. R&D investment intensity is used as the measurement of a firm’s innovation level. The empirical findings suggest that functional background heterogeneity could significantly impede firms’ innovation performance and overseas background has a significantly positive relationship with R&D intensity. Besides, age, gender and educational background heterogeneity could also affect a corporation’s innovation level. The paper concludes by providing academic and practical recommendations on how to strengthen firms' innovation in the Chinese pharmaceutical industry. The research findings also provide opportunities and directions for future research. 2022-06-01 Dissertation (University of Nottingham only) NonPeerReviewed application/pdf en https://eprints.nottingham.ac.uk/67743/1/20220942_BUSI4153_2021_22.pdf Wang, Si-Yu (2022) The effects of board heterogeneity of firm’s innovation - A case study of the Chinese pharmaceutical companies. [Dissertation (University of Nottingham only)] |
| spellingShingle | Wang, Si-Yu The effects of board heterogeneity of firm’s innovation - A case study of the Chinese pharmaceutical companies |
| title | The effects of board heterogeneity of firm’s innovation - A case study of the Chinese pharmaceutical companies |
| title_full | The effects of board heterogeneity of firm’s innovation - A case study of the Chinese pharmaceutical companies |
| title_fullStr | The effects of board heterogeneity of firm’s innovation - A case study of the Chinese pharmaceutical companies |
| title_full_unstemmed | The effects of board heterogeneity of firm’s innovation - A case study of the Chinese pharmaceutical companies |
| title_short | The effects of board heterogeneity of firm’s innovation - A case study of the Chinese pharmaceutical companies |
| title_sort | effects of board heterogeneity of firm’s innovation - a case study of the chinese pharmaceutical companies |
| url | https://eprints.nottingham.ac.uk/67743/ |